The global in vivo toxicology market size is expected to reach USD 7.7 billion by 2028 at a CAGR of 5.4%, according to the latest report by Reports and Data. Increasing research and development activities in pharmaceutical industry, fast innovations in animal models, and rising demand for personalized medicine are primary factors fueling revenue growth of the market.
In-vivo toxicology testing refers to the use of various living organisms for finding out the presence of carcinogenic/toxic chemicals in new substances and the effect of these new substances on humans. These tests can also be performed to confirm the absence of toxic substances or chemicals from drug candidates. Therefore, in-vivo testing has become prevalent in the pre-clinical trials.
Growing demand for novel therapeutics has resulted in increased R&D activities to search for advanced vaccines or drugs. In addition, animal testing is mandatory for determining toxicology profiles, especially for new drugs. These factors are predicted to augment the demand for in-vivo toxicology testing products, propelling the revenue growth of the market going ahead. Furthermore, rapid technical advances in various animal models are also contributing to the revenue growth of the in-vivo toxicology testing market.
However, growing ethical concerns regarding the use of animal models could hinder the market revenue expansion to a certain extent in the coming years. Moreover, questions over the validity of animal models in demonstrating long term toxicity may hamper the market revenue growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4022
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
The Jackson Laboratory (U.S.), Charles River Laboratories (U.S.), Envigo (U.S.), JANVIER LABS (France), Taconic Biosciences, Inc. (U.S.), Thermo Fisher Scientific (U.S.), Waters Corporation (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), and PerkinElmer (U.S.).
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global In Vivo Toxicology market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the In Vivo Toxicology industry, the market is segmented into:
Product Outlook (Revenue, USD Billion, 2018 - 2028)
- Instruments
- Consumables
- Reagents & Kits
- Animal Models
- Mice Models
- Rat Models
- Other Animal Models (Guinea Pigs, Hamsters, Rabbits, and Human Primates)
Test Type Outlook (Revenue, USD Billion, 2018 - 2028)
- Acute
- Sub-acute
- Sub-chronic
- Chronic test type
Testing Facility Outlook (Revenue, USD Billion, 2018 - 2028)
- Outsourced testing facility
- In-house testing facility
Toxicity End Point Outlook (Revenue, USD Billion, 2018 – 2028)
- Immunotoxicity
- Systemic toxicity
- Carcinogenicity
- Genotoxicity
- Developmental & reproductive toxicity (DART)
- Other toxicity endpoints
End User Outlook (Revenue, USD Billion, 2018 – 2028)
- Academic and Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Other End Users
The regional analysis covers:
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- UK.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/in-vivo-toxicology-market
Benefits of In Vivo Toxicology Market Report:
- Panoramic overview of the opportunities and risks in the In Vivo Toxicology sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the In Vivo Toxicology industry
- In-depth assessment of the competitive landscape of the key players of the In Vivo Toxicology industry
- Analysis of the In Vivo Toxicology market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4022
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
